Reflecting on the First Half of 2024
High-level overview of several growing trends in pharma and biotech, with disruptive opportunities (and challenges)
Hi! I am Andrii Buvailo, and this is my weekly newsletter, ‘Where Tech Meets Bio,’ where I talk about technologies, breakthroughs, and great companies moving the biopharma industry forward.
If you've received it, then you either subscribed or someone forwarded it to you. If the latter is the case, subscribe by pressing this button:
If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far!
Last December I compiled a list of 11 Biopharma Trends to Watch in 2024 and I must say, the actual industry developments in all these areas in the first half of 2024 exceeded my expectations. Both in terms of scientific breakthroughs, and in business activity and financing dynamics (except stock markets which are weird in bio space, as usual).
Today, I’ve decided to review where we stand with some of the trends from my Christmas list half a year later, but today I am mostly focusing on the new trends that I picked to expand the list. So, it would still be relevant to check 11 Biopharma Trends to Watch in 2024 for the complete picture.
Enjoy!
